In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective

Creative Commons License

Rahman M. M., Islam M. R., Akash S., Mim S. A., Rahaman M. S., Bin Emran T., ...Daha Fazla

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, cilt.12, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12
  • Basım Tarihi: 2022
  • Doi Numarası: 10.3389/fcimb.2022.929430
  • Dergi Adı: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals
  • Anahtar Kelimeler: virtual screening, drug design, COVID-19, natural products, alkaloids, SARS-CoV-2, PAPAIN-LIKE PROTEASE, TRADITIONAL CHINESE MEDICINE, RESPIRATORY SYNDROME CORONAVIRUS, SARS CORONAVIRUS, TRACE-ELEMENTS, ANTIVIRAL ACTIVITIES, VITAMIN-C, INHIBITORS, HONEY, FLAVONOIDS
  • Gazi Üniversitesi Adresli: Evet

Özet

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a substantial number of deaths around the world, making it a serious and pressing public health hazard. Phytochemicals could thus provide a rich source of potent and safer anti-SARS-CoV-2 drugs. The absence of approved treatments or vaccinations continues to be an issue, forcing the creation of new medicines. Computer-aided drug design has helped to speed up the drug research and development process by decreasing costs and time. Natural compounds like terpenoids, alkaloids, polyphenols, and flavonoid derivatives have a perfect impact against viral replication and facilitate future studies in novel drug discovery. This would be more effective if collaboration took place between governments, researchers, clinicians, and traditional medicine practitioners' safe and effective therapeutic research. Through a computational approach, this study aims to contribute to the development of effective treatment methods by examining the mechanisms relating to the binding and subsequent inhibition of SARS-CoV-2 ribonucleic acid (RNA)-dependent RNA polymerase (RdRp). The in silico method has also been employed to determine the most effective drug among the mentioned compound and their aquatic, nonaquatic, and pharmacokinetics' data have been analyzed. The highest binding energy has been reported -11.4 kcal/mol against SARS-CoV-2 main protease (7MBG) in L05. Besides, all the ligands are non-carcinogenic, excluding L04, and have good water solubility and no AMES toxicity. The discovery of preclinical drug candidate molecules and the structural elucidation of pharmacological therapeutic targets have expedited both structure-based and ligand-based drug design. This review article will assist physicians and researchers in realizing the enormous potential of computer-aided drug design in the design and discovery of therapeutic molecules, and hence in the treatment of deadly diseases.